Stocks to Sell

Stocks can plunge for any number of reasons — investors may need to raise cash for large milestone purchases, or algorithms could be triggered by stop losses which create massive selloffs. Whatever the case, InvestorPlace’s journalists weed out the markets’ losers, keeping you informed of which stocks to cash out of before they come crashing down.

Don’t Fall for Peloton Stock’s Latest Rally

By Louis Navellier and the InvestorPlace Research Staff
PTON stock has begun to rally again, but it probably won't get far as controversies and supply chain problems weigh it down.

Moderna’s Outlook Is Directly Tied to the Eventual Receding of Covid-19

By Muslim Farooque, InvestorPlace Contributor
With Covid-19 receding and a one-dimensional product pipeline, MRNA stock is a one-trick-pony without any long-term prospects.

Ocugen Neared $16 Yesterday, But I’ll Eat 4 Hats If It Gets to $32

By Will Ashworth, InvestorPlace Contributor
OCGN stock has moved higher despite little evidence anything’s changed regarding Ocugen’s revenue potential in the U.S.

SPCE Could Fall Even Further Than Ground Level

By Mark R. Hake, CFA
Virgin Galactic stock could fall further even though it's at a trough. SPCE stock is not worth investing in just yet until it's clear whether its cash will cover the ongoing cash burn.

Many Factors Could Still Sink Palantir Stock

By Thomas Niel, InvestorPlace Contributor
As Palantir's risk continues to vastly exceed its near-term potential gains, steering clear of PLTR stock remains your best move.

With its Current Prognosis, Avoid Teladoc Stock

By Louis Navellier and the InvestorPlace Research Staff
With its current prognosis calling for another drop in price, steer clear of TDOC stock.

Lucid Stock Is Valued Like an Industry Leader Rather Than a Newcomer

By Dana Blankenhorn, InvestorPlace Contributor
Lucid is getting rapturous reviews for its Air sedan, but its future depends on scaling production of lower-priced vehicles

It’s Time to Follow the Money Out of Vinco Ventures Stock

By Chris Tyler, InvestorPlace Contributor
BBIG stock investors are free to believe what they want, but the charts for Vinco Ventures show an ugly picture.

At Some Point, GameStop Investors Will Heed This Simple Warning

By Alex Sirois, InvestorPlace Contributor
GME stock is going to hurt those who continue to think that it has changed the game. It hasn't, and the hammer will drop soon enough.

7 Retail Stocks That Will Be Six Feet Under in 2022

By Thomas Niel, InvestorPlace Contributor
Facing many challenges, expect these seven retail stocks to experience to a big drop in price over the next twelve months.

An Approval by WHO Would Not Help Ocugen

By Alex Sirois, InvestorPlace Contributor
Ocugen is forging ahead with its plans for regulatory approval, but that doesn't make OCGN stock any more worthy of your capital.

Blackberry Stock Isn’t Worth Your Attention After This Improbable Bump

By Alex Sirois, InvestorPlace Contributor
BB stock hasn't turned things around despite some headlines suggest. Its meme status is fizzling also and no one should remain interested.

Peloton Stock Looks to Be Just Spinning Its Wheels at This Point

By Marie Brodbeck, InvestorPlace Contributor
PTON stock still has a lot to prove before it will be a good investment-- the bike price cut is a step in the right direction, but the proof's in the pudding. If bikes don't fly off shelves this winter, the business could be in trouble.

Progenity Offers Nothing That Dozens of Other Biotechs Don’t

By Alex Sirois, InvestorPlace Contributor
PROG stock should suffer dilution but its IP strength will lure some in nonetheless. It looks like a biotech to avoid.

SmileDirectClub Needs to Become Profitable to Be a Worthy Investment

By Stavros Georgiadis, CFA, InvestorPlace Contributor
SmileDirectClub (NASDAQ:SDC) is an oral care company founded in 2014. Headquartered in Nashville, the company operates in the North America, Europe and Asia Pacific regions. Its…

Aterian Is Hard to Recommend With a Cash Crunch and a Potential Dilution

By David Moadel, InvestorPlace Contributor
ATER stock was seemingly short-squeezed in early 2021, and this could happen again. But in the meantime, there are major issues to consider.

Pinterest Is a Coronavirus Play Whose Time Has Passed

By Patrick Sanders, InvestorPlace Contributor
Pinterest had an amazing rise as Covid-19 fears shut the nation down in 2020. But now it appears that the run for PINS stock is over.

4 Reasons Why Ocugen Will Make Very Little or No Money From Covaxin

By Larry Ramer, InvestorPlace Contributor
Ocuigen is unlikely to be able to get Covaxin widely distributed in the U.S. until Spring 2023. By that time, the shot won't help OCGN stock much if at all.

Microvision Q3 Earnings Show That MVIS Stock Is Dead Money… For Now

By Joanna Makris, Head of Equity Research, Boardroom Alpha
A sloppy print and delayed gratification from Microvision's Q3 earnings report have crashed and burned MVIS stock. Does any hope remain?
Load More Articles